Benzinga · Sep 11, 2026
Ascendiant Capital Maintains Buy on Pro-Dex, Raises Price Target to $74
Ascendiant Capital analyst Edward Woo maintains Pro-Dex (NASDAQ:PDEX) with a Buy and raises the price target from $70 to $74.
PD
NASDAQ · PDEX
Pro-Dex, Inc.
Healthcare · Medical - Instruments & Supplies
$73.02
Down-$1.25 (-1.71%)
Updated Sep 25, 2026, 9:01 PM
SID Score
6.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 142.87M
- P/E ratio
- 12.77
- Dividend yield
- 0.00%
- 52-week range
- $43.27 – $77.00
- Volume
- 39.51K
- Avg. volume
- 50.3K
Price performance
PDEX price history
1M range · 20 trading sessions · Daily adjusted prices
PDEX closed at $73.02 after 20 trading sessions, up 12.58% for the selected period.
- Last close
- $73.02
- Period change
- +12.58%
- Period low
- $59.84
- Period high
- $73.41
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 24, 2026 | $70.81 | $74.00 | $70.80 | $73.02 | 39.51K |
| Sep 23, 2026 | $72.38 | $72.76 | $70.52 | $71.94 | 96.36K |
| Sep 22, 2026 | $72.84 | $73.50 | $71.97 | $72.41 | 42.37K |
| Sep 21, 2026 | $72.70 | $73.40 | $71.20 | $72.52 | 75.93K |
| Sep 18, 2026 | $70.29 | $73.29 | $69.555 | $72.55 | 84.68K |
| Sep 17, 2026 | $72.48 | $73.50 | $68.97 | $69.475 | 56.17K |
| Sep 16, 2026 | $67.58 | $72.89 | $67.05 | $71.85 | 105.65K |
| Sep 15, 2026 | $66.03 | $68.30 | $65.95 | $66.91 | 70.65K |
| Sep 14, 2026 | $62.80 | $69.10 | $62.57 | $66.56 | 126.57K |
| Sep 11, 2026 | $59.84 | $63.565 | $59.39 | $62.805 | 63.04K |
| Sep 10, 2026 | $59.89 | $60.31 | $58.04 | $59.84 | 65.56K |
| Sep 9, 2026 | $65.65 | $66.40 | $58.45 | $60.70 | 153.68K |
| Sep 8, 2026 | $73.95 | $73.95 | $66.25 | $66.41 | 106.82K |
| Sep 4, 2026 | $69.54 | $77.00 | $69.54 | $73.41 | 150.24K |
| Sep 3, 2026 | $62.56 | $63.3123 | $60.20 | $61.75 | 64.74K |
| Sep 2, 2026 | $62.27 | $63.20 | $62.085 | $62.58 | 33.82K |
| Sep 1, 2026 | $61.90 | $63.195 | $59.92 | $61.40 | 92.08K |
| Aug 31, 2026 | $62.76 | $63.575 | $61.84 | $62.10 | 33.63K |
| Aug 28, 2026 | $64.89 | $64.89 | $62.17 | $62.555 | 56.66K |
| Aug 27, 2026 | $63.93 | $66.36 | $63.93 | $64.86 | 57.44K |
Latest PDEX news
The latest Smart Investors Daily articles mentioning PDEX.
Stock researchCompany · Overview
PDEX research
Overview
Company profile and research snapshot.
Company profile
Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries. Its product portfolio includes autoclavable, battery-powered, electric, and multi-function surgical drivers and shavers used mainly in orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, regulatory consulting services, and manufactures rotary air motors utilized in various industries. Operating out of ISO-certified facilities in California, Pro-Dex serves hospitals, medical labs, and high-tech manufacturers, generating revenue through sales of surgical instruments and related services.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 11, 2026 | Ascendiant Capital | Buy | — |
| May 12, 2026 | Ascendiant Capital | Buy | — |
| May 27, 2025 | Ascendiant Capital | Buy | — |
| Nov 11, 2024 | Ascendiant Capital | Buy | — |
| Sep 9, 2024 | Ascendiant Capital | Buy | — |
News briefing
No generated briefing is available yet.
Yahoo · Sep 4, 2026
Dell Afterglow Continues. These Other Stocks Top Buy Points.
Dell Technologies' superb earnings report is still reverberating across the stock market, as the stock climbed to a new high Friday.
Yahoo · Sep 3, 2026
Pro-Dex, Inc. Announces Fiscal 2026 Fourth Quarter and Full-Year Results
IRVINE, CA / ACCESS Newswire / September 3, 2026 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2026 fourth quarter and full-year ended June 30, 2026.
Benzinga · Sep 3, 2026
Pro-Dex Q4 EPS $0.87 Beats $0.67 Estimate, Sales $20.405M Beat $19.200M Estimate
Pro-Dex (NASDAQ:PDEX) reported quarterly earnings of $0.87 per share which beat the analyst consensus estimate of $0.67 by 29.85 percent. This is a 141.67 percent increase over earnings of $0.36 per share from the same
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
